BiotechTube
Home/Pipeline/Isosorbide Dinitrate/Hydralazine HCl Tablets

Isosorbide Dinitrate/Hydralazine HCl Tablets

Heart Failure

ApprovedActive

Key Facts

Indication
Heart Failure
Phase
Approved
Status
Active
Company
i3 Pharmaceuticals

About i3 Pharmaceuticals

i3 Pharmaceuticals is a specialty generic drug company founded by industry veterans to address high-barrier, complex solid oral dosage forms. The company's strategy centers on applying deep technical know-how to develop and manufacture generics for poorly soluble, unstable, or potent compounds, with a fully integrated US-based facility for development through commercial supply. Since its operational launch, i3 has successfully passed FDA inspections and commercialized several products, positioning itself in the niche but valuable market for technically challenging generics.

View full company profile

Therapeutic Areas

Infectious DiseaseCardiologyCentral Nervous SystemOther Specialty

Other Heart Failure Drugs

DrugCompanyPhase
Cardiac Cell Therapy ProgramStemCardiaPre-clinical
NTP42ATXA TherapeuticsPreclinical
Heart Failure TrialClinical Investigation SpecialistsNot Specified
INPEFA (sotagliflozin)Lexicon PharmaceuticalsApproved
MyCardia™Avery TherapeuticsPre-clinical
Cardiac Assist DeviceSecond Heart AssistPre-clinical
TLT-101TikkunLev TherapeuticsPre-clinical
Undisclosed Heart Regeneration ProgramAnimatus BiosciencesPre-clinical
AFteR RegistryOcclutechN/A (Registry)
biotx.ai Target Discovery CollaborationHeartBeat.bioPre-clinical
SurlorianRyCarma TherapeuticsPhase 2
Coronary Sinus ReductionShockwave MedicalUnknown